The influence of accessibility of anticancer drug therapy on the target indicators of the oncological service

Yazar: V. V. Petkau, А. А. Karimova, S. А. Efremov, Е. А. Gruzdeva
Baskı/Yayın Bilgisi 2021-06-01

Oncological care for the patients with hepatocellular carcinoma in COVID-19 pandemic

Yazar: V. V. Petkau, V. V. Breder, E. N. Bessonova, K. K. Laktionov, I. S. Stilidi
Baskı/Yayın Bilgisi 2020-07-01

Interdisciplinary model of patient care for groups at risk for malignant tumors of the skin

Yazar: M. A. Ufimtseva, A. S. Shubina, V. V. Petkau, N. L. Struin, D. E. Emel'janov, E. A. Levchenko
Baskı/Yayın Bilgisi 2019-10-01

Survival of patients with metastatic bladder cancer in the Russian Federation: results of a multicenter registry study URRU

Yazar: I. V. Tsimafeyeu, G. N. Alekseeva, V. V. Petkau, R. A. Zukov, M. S. Mazhbich, A. V. Semenov, G. B. Statsenko, O. Yu. Novikova, I. V. Zaytsev, I. L. Popova, L. I. Gurina, M. A. Mukhina, L. Yu. Vladimirova
Baskı/Yayın Bilgisi 2021-11-01

Toxicity and efficacy of biosimilar bevacizumab in the second-line therapy for metastatic colon cancer in routine clinical practice: results of an independent observational study

Yazar: M.   Yu. Fedyanin, F.   V. Moiseenko, M.   A. Lyadova, V.  N.  Vorobyeva, V.  V.  Petkau, A.  V.  Fateeva, E.  S.  Kuzmina, O.  Yu.  Novikova, V.   A. Chubenko, N.  Kh.  Abduloeva, A.  A.  Kudryavtsev, E.   O. Ignatova, R.   R. Shakirov, O.  A.  Pardabekova, L.  V.  Kindyalova, S.  P.  Pelikh, O.   A. Gladkov, S.  A.  Tjulandin, A.  A.  Tryakin
Baskı/Yayın Bilgisi 2021-06-01